Report Algeria - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Algeria - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Algeria: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Algeria

The Algerian medicaments containing insulin market shrank modestly to $X in 2021, which is down by -4.4% against the previous year. Over the period under review, consumption recorded a mild contraction. As a result, consumption reached the peak level of $X. From 2018 to 2021, the growth of the market remained at a somewhat lower figure.

Medicaments Containing Insulin Production in Algeria

In value terms, medicaments containing insulin production contracted to $X in 2021 estimated in export price. In general, production, however, saw a noticeable downturn. The pace of growth appeared the most rapid in 2020 with an increase of 12%. Over the period under review, production hit record highs at $X in 2012; however, from 2013 to 2021, production failed to regain momentum.

Medicaments Containing Insulin Exports

Exports from Algeria

For the third consecutive year, Algeria recorded growth in shipments abroad of medicaments containing insulin but not antibiotics, which increased by 20% to X kg in 2021. In general, exports, however, continue to indicate a deep downturn. The exports peaked at X kg in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports expanded notably to $X in 2021. Over the period under review, exports, however, saw a noticeable reduction. Over the period under review, the exports attained the peak figure at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

Denmark (X kg) was the main destination for medicaments containing insulin exports from Algeria, with a approx. 50% share of total exports.

From 2017 to 2021, the average annual rate of growth in terms of volume to Denmark was relatively modest.

In value terms, Denmark ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from Algeria.

From 2017 to 2021, the average annual rate of growth in terms of value to Denmark was relatively modest.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, shrinking by -12.5% against the previous year. In general, the export price, however, saw buoyant growth. Over the period under review, the average export prices hit record highs at $X per ton in 2020, and then shrank in the following year.

As there is only one major export destination, the average price level is determined by prices for Denmark.

From 2017 to 2021, the rate of growth in terms of prices for Denmark amounted to 0.0% per year.

Medicaments Containing Insulin Imports

Imports into Algeria

In 2017, imports of medicaments containing insulin but not antibiotics into Algeria surged to X kg, rising by 350% against 2016 figures. Overall, imports saw a significant expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing insulin imports contracted rapidly to $X in 2017. Over the period under review, imports showed a buoyant expansion. The most prominent rate of growth was recorded in 2014 with an increase of 246%. Over the period under review, imports attained the maximum at $X in 2016, and then dropped significantly in the following year.

Imports by Country

In 2017, Germany (X kg) was the main medicaments containing insulin supplier to Algeria, accounting for a 92% share of total imports. Moreover, medicaments containing insulin imports from Germany exceeded the figures recorded by the second-largest supplier, Denmark (X kg), more than tenfold.

From 2012 to 2017, the average annual growth rate of volume from Germany was relatively modest.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Algeria, comprising 91% of total imports. The second position in the ranking was held by Denmark ($X), with an 8.6% share of total imports.

From 2012 to 2017, the average annual rate of growth in terms of value from Germany was relatively modest.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2017, with a decrease of -96.4% against the previous year. Overall, the import price recorded a significant decrease. The pace of growth was the most pronounced in 2014 an increase of 92%. Over the period under review, average import prices reached the peak figure at $X per ton in 2016, and then fell significantly in the following year.

Average prices varied noticeably amongst the major supplying countries. In 2017, amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Germany amounted to $X per ton.

From 2013 to 2017, the most notable rate of growth in terms of prices was attained by Denmark (0.0%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Denmark remains the largest medicaments containing insulin consuming country worldwide, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.
The U.S. constituted the country with the largest volume of medicaments containing insulin production, comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.
In value terms, Germany $106) constituted the largest supplier of medicaments containing insulin to Algeria, comprising 91% of total imports. The second position in the ranking was occupied by Denmark $10), with a 8.6% share of total imports.
The average medicaments containing insulin export price stood at $39,600 per ton in 2020, flattening at the previous year.
The average medicaments containing insulin import price stood at $3,241 per ton in 2017, dropping by -93.6% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Algeria. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

  • Algeria

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Algeria
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Insulin But Not Antibiotics - Algeria